Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma

MeSH terms

• Acute Disease
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Biomarkers / blood
• Biomarkers, Tumor / blood
• Brain Neoplasms / complications
• Brain Neoplasms / drug therapy*
• Brain Neoplasms / secondary
• Databases, Factual
• Disseminated Intravascular Coagulation / blood
• Disseminated Intravascular Coagulation / chemically induced*
• Disseminated Intravascular Coagulation / diagnosis
• Disseminated Intravascular Coagulation / etiology
• Drug Administration Schedule
• Fatal Outcome
• Fibrin Fibrinogen Degradation Products / drug effects
• Fibrinogen / metabolism
• Humans
• Indoles / administration & dosage
• Indoles / adverse effects*
• L-Lactate Dehydrogenase / blood
• Male
• Melanoma / complications
• Melanoma / drug therapy*
• Melanoma / genetics
• Melanoma / secondary
• Middle Aged
• Mutation*
• Pharmacovigilance*
• Platelet Count
• Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
• Proto-Oncogene Proteins B-raf / genetics
• Recurrence
• S100 Calcium Binding Protein beta Subunit / blood
• Skin Neoplasms / complications
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / genetics
• Skin Neoplasms / pathology
• Sulfonamides / administration & dosage
• Sulfonamides / adverse effects*
• Tumor Burden / drug effects
• Vemurafenib